Research summary ·
Systematic review and meta-analysis of hypersensitivity reactions after high-dose IV iron.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This study looked at serious allergic reactions to iron given into a vein. The iron was used to treat anemia caused by low iron. The team compared FDI, FCM and FER. FDI is ferric derisomaltose. FCM is ferric carboxymaltose, and FER is ferumoxytol. They searched for trials where people were put into groups by chance. Then they pooled the results with a math model. In total, the trials had 11 268 patients.
What they found
Serious or severe allergic reactions were uncommon with each of the drugs. FDI had the fewest of these reactions. The pooled results pointed to a lower risk with FDI than with FCM. The risk with FDI also looked lower than with FER. A ranking method found FDI was the drug most likely to have the lowest rate.
What it means for patients
The authors call this a full look at serious allergic reactions. It covers the high-dose iron drugs that can be given fast. The results add to what is known about how safe each drug is. FDI may carry a lower risk of these reactions than FCM or FER.
Why it is not certain yet
These reactions were uncommon, so there were few events to study. The ranges around the risk results were wide. So the results do not rule out that the drugs carry the same risk. The abstract does not say how long people were followed. A review can only be as good as the studies in it.
Source
Systematic review and meta-analysis of hypersensitivity reactions after high-dose IV iron.
PubMed · PMID 42747867We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Iron deficiency anaemia publications